Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 18, 2012

View Archived Issues

Genetic alterations linked to immune function dysregulation with cold urticaria

New hepatitis C virus NS5A inhibitor identified and characterized

Full results published of phase III breast cancer study CLEOPATRA

Researchers at Novartis present new insulin-like growth factor 1 receptor antagonists

U.S. team designs novel series of antibacterial agents

Ardea Biosciences discloses new inhibitors of urate transport

Novel agents for HIV infection synthesized in Korea

One-pot cascade synthesis yields modulators of centrosome integrity

New muscarinic acetylcholine M1 receptor positive allosteric modulators patented

Roche technology used to identify mutations underlying hearing loss

Idenix Pharmaceuticals provides update on agents for hepatitis C

Lunesta approved for Japanese market

Gilead Sciences completes acquisition

DARA BioSciences announces acquisitions

Medivation and Pfizer report data from phase III CONCERT trial

Ranmark approved in Japan

Takeda's Azilva approved in Japan

Niiki Pharma completes first-in-human trial of anticancer agent

Pevion reports encouraging data on PEV-7 for recurrent vulvovaginal candidiasis

FDA approves new product for methotrexate poisoning due to impaired renal function

Abilify approved for new indication in Japan

OxiFast approved in Japan for cancer pain

Xarelto approved in Japan for prevention of stroke and systemic embolism in patients with AF

Phase II tivantinib study in second-line hepatocellular carcinoma meets primary endpoint

Regnite approved in Japan for restless legs syndrome

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...